Tailoring care to haemophilia patients' needs: Which specialty and when?

Blood Transfusion

Volumn 13, Issue 4, 2015, Pages 644-650

  Morfini, Massimo ^a   Benson, Gary ^b   Jiménez Yuste, Victor J ^c   Ljung, Rolf ^d   Mannucci, Pier Mannuccio ^e   Pasta, Gianluigi ^e   Remor, Eduardo ^f   Salek, Silva Zupančić ^g  

^a Past President of AICE   (Italy)

^b Northern Ireland Haemophilia Comprehensive Care Centre   (United Kingdom)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^d LUND UNIVERSITY   (Sweden)

^e FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^f UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^g KBC Zagreb   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; DESMOPRESSIN;

ARTHROPATHY; DISEASE SURVEILLANCE; HEMOPHILIA; HUMAN; IMAGING; INFECTION; PHYSIOTHERAPY; PROPHYLAXIS; PSYCHOSOCIAL CARE; REVIEW; ADULT; AGED; CARDIOVASCULAR DISEASES; CHILD; DIAGNOSTIC IMAGING; DISEASE MANAGEMENT; ELDERLY CARE; EUROPE; HEALTH; HEALTH SERVICE; HEMATOLOGY; HEMOPHILIA A; INFECTION CONTROL; LONGEVITY; MEDICAL SOCIETY; MEDICINE; ORGANIZATION AND MANAGEMENT; PATIENT CARE; PERSONALIZED MEDICINE; PRACTICE GUIDELINE; PSYCHOLOGY; SOCIAL SUPPORT;

ADULT; AGED; CARDIOVASCULAR DISEASES; CHILD; DIAGNOSTIC IMAGING; DISEASE MANAGEMENT; EUROPE; GLOBAL HEALTH; HEALTH SERVICES FOR THE AGED; HEALTH SERVICES NEEDS AND DEMAND; HEMATOLOGY; HEMOPHILIA A; HUMANS; INFECTION CONTROL; LONGEVITY; MEDICINE; PATIENT CARE TEAM; PATIENT-CENTERED CARE; PHYSICAL THERAPY MODALITIES; PRACTICE GUIDELINES AS TOPIC; PRECISION MEDICINE; SOCIAL SUPPORT; SOCIETIES, MEDICAL;

EID: 84949664805     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2015.0302-14     Document Type: Review

References (37)

1. Srivastava A, Brewer AK, Mauser-Bunschoten EP, et al. Guidelines for the management of hemophilia. Haemophilia 2013; 19: e1-47.
2. European guidelines for certification of Haemophilia Centres. European Haemophilia Network (EUHANET). Available at: http://www.euhanet.org/docs/Euhanet-European-guidelines-for-The-certification-of-Haemophilia-Centres0-2013.pdf. Accessed on 11/03/2014.
3. Wilde JT. The UK Haemophilia Doctors Organisation triennial audit of UK Comprehensive Care Haemophilia Centres. Haemophilia 2012; 18: 491-5.
4. O'Mahony B, Noone D, Giangrande PL, Prihodova L. Haemophilia care in Europe: A survey of 19 countries. Haemophilia 2011; 17: 35-40.
5. O'Mahony B, Noone D, Giangrande PL, Prihodova L. Haemophilia care in Europe-A survey of 35 countries. Haemophilia 2013; 19: e239-47.
6. Berntorp E, Shapiro AD. Modern haemophilia care. Lancet 2012; 379: 1447-56.
7. Collins PW, Fischer K, Morfini M, et al. Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia. Haemophilia 2011; 17: 2-10.
8. Ette EI, Williams PJ, Lane JR. Population pharmacokinetics III: design, analysis, and application of population pharmacokinetic studies. Ann Pharmacother 2004; 38: 2136-44.
9. Validation Study of a cOmputer Pharmacokinetic Tool to assIst in the Follow up Care of haeMophilia A Patients (OPTIMS). Bayer HealthCare. Available at: http://clinicaltrials.gov/show/ NCT01436825. Accessed on 03/09/2014.
10. de Moerloose P, Fischer K, Lambert T, et al. Recommendations for assessment, monitoring and follow-up of patients with haemophilia. Haemophilia 2012; 18: 319-25.
11. Pettersson H, Ahlberg A, Nilsson IM. A radiologic classification of hemophilic arthropathy. Clin Orthop Relat Res 1980; 149: 153-9.
12. Arnold WD, Hilgartner MW. Hemophilic arthropathy. Current concepts of pathogenesis and management. J Bone Joint Surg Am 1977; 59: 287-305.
13. Chan MW, Leckie A, Xavier F, et al. A systematic review of MR imaging as a tool for evaluating haemophilic arthropathy in children. Haemophilia 2013; 19: e324-34.
14. Valentino LA. Blood-induced joint disease: The pathophysiology of hemophilic arthropathy. J Thromb Haemost 2010; 8: 1895-902.
15. Martinoli C, Della Casa Alberighi O, Di Minno G, et al. Development and definition of a simplified scanning procedure and scoring method for Haemophilia Early Arthropathy Detection with Ultrasound (HEAD-US). Thromb Haemost 2013; 109: 1170-9.
16. Broderick CR, Herbert RD, Latimer J, et al. Association between physical activity and risk of bleeding in children with hemophilia. JAMA 2012; 308: 1452-9.
17. Negrier C, Seuser A, Forsyth A, et al. The benefits of exercise for patients with haemophilia and recommendations for safe and effective physical activity. Haemophilia 2013; 19: 487-98.
18. Corte-Rodriguez H, Rodriguez-Merchan EC. The role of physical medicine and rehabilitation in haemophiliac patients. Blood Coagul Fibrinolysis 2013; 24: 1-9.
19. Forsyth AL, Quon DV, Konkle BA. Role of exercise and physical activity on haemophilic arthropathy, fall prevention and osteoporosis. Haemophilia 2011; 17: e870-6.
20. Morfini M, Haya S, Tagariello G, et al. European study on orthopaedic status of haemophilia patients with inhibitors. Haemophilia 2007; 13: 606-12.
21. Rodriguez-Merchan EC, Jimenez-Yuste V. The role of selective angiographic embolization of the musculo-skeletal system in haemophilia. Haemophilia 2009; 15: 864-8.
22. Fernandez-Palazzi F. Treatment of acute and chronic synovitis by non-surgical means. Haemophilia 1998; 4: 518-23.
23. Rodriguez-Merchan EC. Methods to treat chronic haemophilic synovitis. Haemophilia 2001; 7: 1-5.
24. Goddard NJ, Rodriguez-Merchan EC, Wiedel JD. Total knee replacement in haemophilia. Haemophilia 2002; 8: 382-6.
25. Bluth BE, Fong YJ, Houman JJ, et al. Ankle fusion in patients with haemophilia. Haemophilia 2013; 19: 432-7.
26. Spilsbury M. Models for psychosocial services in the developed and developing world. Haemophilia 2004; 10 (Suppl 4): 25-9.
27. Franchini M, Mannucci PM. Hemophilia A in the third millennium. Blood Rev 2013; 27: 179-84.
28. Tagliaferri A, Rivolta GF, Iorio A, et al. Mortality and causes of death in Italian persons with haemophilia, 1990-2007. Haemophilia 2010; 16: 437-46.
29. Dolan G. The challenge of an ageing haemophilic population. Haemophilia 2010; 16 (Suppl 5): 11-6.
30. Franchini M, Mannucci PM. Co-morbidities and quality of life in elderly persons with haemophilia. Br J Haematol 2010; 148: 522-33.
31. Siboni SM, Mannucci PM, Gringeri A, et al. Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy. J Thromb Haemost 2009; 7: 780-6.
32. Hay CR, Palmer B, Chalmers E, et al. Incidence of factor VIII inhibitors throughout life in severe hemophilia A in the United Kingdom. Blood 2011; 117: 6367-70.
33. Sharathkumar AA, Soucie JM, Trawinski B, et al. Prevalence and risk factors of cardiovascular disease (CVD) events among patients with haemophilia: experience of a single haemophilia treatment centre in the United States (US). Haemophilia 2011; 17: 597-604.
34. Mauser-Bunschoten EP, Fransen Van De Putte DE, Schutgens RE. Co-morbidity in the ageing haemophilia patient: The down side of increased life expectancy. Haemophilia 2009; 15: 853-63.
35. Schutgens RE, Klamroth R, Pabinger I, Dolan G. Management of atrial fibrillation in people with haemophilia-A consensus view by the ADVANCE Working Group. Haemophilia 2014; 20: e417-20.
36. Mannucci PM, Schutgens RE, Santagostino E, Mauser-Bunschoten EP. How I treat age-related morbidities in elderly persons with hemophilia. Blood 2009; 114: 5256-63.
37. Hermans C, de MP, Dolan G. Clinical management of older persons with haemophilia. Crit Rev Oncol Hematol 2014; 89: 197-206.